AI assistant
Kezar Life Sciences, Inc. — Director's Dealing 2018
Jun 20, 2018
34845_dirs_2018-06-20_9175451a-4282-4211-b154-47b2a63eccbb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2018-06-20
Reporting Person: Cormorant Asset Management, LP (10% Owner)
Reporting Person: Cormorant Global Healthcare Master Fund, LP (10% Owner)
Reporting Person: CORMORANT PRIVATE HEALTHCARE FUND I, LP (10% Owner)
Reporting Person: Chen Bihua (Director, 10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Redeemable Convertible Preferred Stock | $ | Common Stock (315488) | Direct | ||
| Series B redeemable Convertible Preferred Stock | $ | Common Stock (1007421) | Direct |
Footnotes
F1: The convertible preferred stock is convertible at any time at the holder's election, without payment of additional consideration, and has no expiration date but is expected to convert automatically upon the closing of the Issuer's initial public offering.
F2: Series A Redeemable Convertible Preferred Stock reported herein represent, on an as-converted basis, (i) 265,799 shares held by Cormorant Global Healthcare Master Fund, LP (the "Master Fund") and (ii) 49,689 shares held by a managed account (the "Account").
F3: Series B Redeemable Convertible Preferred Stock reported herein represent, on an as-converted basis, (i) 803,116 shares held by Cormorant Private Healthcare Fund I, LP ("Fund I"), (ii) 169,952 shares held by the Master Fund, and (iii) 34,353 shares held by the Account.
F4: Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Fund I, the Master Fund and the Account. Bihua Chen serves as manager of the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.